Beprogel

Beprogel

betamethasone

Manufacturer:

Taisho

Distributor:

Zuellig
/
Firma Chun Cheong
Full Prescribing Info
Contents
Betamethasone dipropionate.
Description
Each ml contains 0.64 mg of betamethasone dipropionate (equivalent to 0.5 mg of betamethasone) with methyl paraben 0.1% as preservative.
Action
Pharmacology: Betamethasone dipropionate has anti-inflammatory, anti-pruritic, and vasoconstrictive actions. When administered topically, particularly under occlusive dressings or when the skin is broken, sufficient corticosteroid may be absorbed to give systemic effects. Corticosteroids are extensively bound to plasma proteins. Only unbound corticosteroids have pharmacological effects or are metabolized. They are metabolized mainly in the liver, also in the kidneys, and are excreted in the urine.
Indications/Uses
Suppression of skin diseases in which inflammation is a prominent feature, eg. eczema, atopic dermatitis, dermatitis herpetiformis, contact dermatitis, dermatitis venenata, seborrhoeic dermatitis, neurodermatitis, psoriasis and intertrigo.
Contraindications
Hypersensitivity to betamethasone dipropionate, other corticosteroids, or any component in the base. Topical corticosteroids are contraindicated in most viral infections of the skin, such as vaccinia, varicella, and Herpes simplex, also tuberculosis and acne rosacea.
Special Precautions
Discontinue use if irritation or sensitivity develops. Safety of its use during pregnancy and lactation has not been established. Thus it should be used only if the potential benefit justifies the potential risk to the foetus or nursing infant. Special care must be taken when giving to paediatric patients as systemic absorption can occur in topical administration causing growth retardation. Caution is advised if the medication is to be applied to extensive surface area or under occlusive dressing. Not suitable for ophthalmic use.
Adverse Reactions
Report local adverse reactions are burning, itching, irritation, dryness folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, maceration of the skin, secondary infection, skin atrophy, striae and miliria. Large doses of corticosteroids may produce symptoms typical of hyperactivity of the adrenal cortex, with moon face, sometimes with hirsutism, buffalo hump, flushing, sometimes leading to a fully developed Cushing's syndrome.
Drug Interactions
Unknown.
Storage
Keep container well closed. Protect from strong light. Store below 30°C.
Recommended shelf-life: 3 years.
Patient Counseling Information
Wash and dry affected area. Apply Beprogel Topical Solution sparingly to the affected areas and rub in once or twice daily as directed by the doctor or pharmacist. If symptoms persist please consult the doctor or pharmacist. This preparation is for the treatment of the current condition only. Do not allow use by any other person and dispose off unused material when the treatment is complete.
ATC Classification
D07AC01 - betamethasone ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.
Presentation/Packing
Topical soln 0.064% (colourless, slightly viscous solution) x 30 mL.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in